Opioid Rotation: The Science and the Limitations of the Equianalgesic Dose Table

Abstract

Opioid rotation refers to a switch from one opioid to another in an effort to improve the response to analgesic therapy or reduce adverse effects. It is a common method to address the problem of poor opioid responsiveness despite optimal dose titration. Guidelines for opioid rotation are empirical and begin with the selection of a safe and reasonably effective starting dose for the new opioid, followed by dose adjustment to optimize the balance between analgesia and side effects. The selection of a starting dose must be based on an estimate of the relative potency between the existing opioid and the new one. Potency, which is defined as the dose required to produce a given effect, differs widely among opioids, and among individuals under varying conditions. To effectively rotate from one opioid to another, the new opioid must be started at a dose that will cause neither toxicity nor abstinence, and will be sufficiently efficacious in that pain is no worse than before the change. The estimate of relative potency used in calculating this starting dose has been codified on "equianalgesic dose tables," which historically have been based on the best science available and have been used with little modification for more than 40 years. These tables, and the clinical protocols used to apply them to opioid rotation, may need revision, however, as the science underlying relative potency evolves. Review of these issues informs the use of opioid rotation in the clinical setting and defines key areas for future research.

Switching from oxycodone to methadone in advanced cancer patients

“…Specifically, the lack of reliable equianalgesic conversion ratios, increased potency associated with methadone in patients previously exposed to high-dose opioids, large interindividual variability in methadone pharmacokinetics, and the potential for pharmacological interaction with other drugs have made the clinical use of methadone difficult. Systematic reviews on switching to methadone have shown a large heterogeneity in terms of opioid ratios, outcomes, and modality of switching utilized [4,5,10,15,16]. The dose of methadone cannot be easily predicted as it will depend on a series of factors, including individual response, pharmacodynamics, pain mechanism, pharmacogenetics, and degree of cross-tolerance [4].…”

Pharmacologic and Non-Pharmacologic Treatment of Osteoarthritis

“…Opioid analgesics can be given by mouth, as an injection or through transdermal patch [47]. Oral opioid analgesics can be classified based on their analgesic potencies [48].…”

Opioid therapy for chronic non-cancer pain: guidelines for Hong Kong

“…73 This occurrence may be explained by genetic variations in receptor subtypes that modulate drug effects, and that also potentially promote incomplete cross-tolerance among opioids. 74 Opioid rotation involves selection of a new opioid, determination of its appropriate initial dose, and subsequent titration for a satisfactory balance of efficacy and side-effects. 70 Use of an equianalgesic table can facilitate estimation of the new drug's initial dose.…”